GLUCOSE HEALTH INC - GLUC STOCK NEWS

Glucose Health, Inc. has been granted registered trademark status for its innovative new brand, 'Fiber UP®' by the United States Patent and Trademark Office. This confirms the brand's status in the Amazon Brand Registry, strengthening its position in the online marketplace. Fiber UP® offers clinically proven dietary fiber support for metabolic health, with low calories and delicious flavors. Shareholders, investors, and consumers are encouraged to visit Glucose Health, Inc.'s Amazon storefronts to experience the brand's products.

Glucose Health, Inc. (GLUC) successfully launched FIBER UP, a prebiotic soluble fiber infused drink mix, at Amazon in November 2023. The brand has achieved impressive sales and positive consumer feedback, surpassing the success of GLUCODOWN. FIBER UP offers two delicious flavors and has secured additional working capital to support its growth. Both FIBER UP and GLUCODOWN are backed by scientific evidence and clinical studies, positioning them as trusted solutions for metabolic health and overall well-being.

Over 10,000 consumers have posted top reviews of GLUCODOWN® at Amazon, indicating strong consumer trust and satisfaction with the brand.

GLUCODOWN® Peach Mango sales increased 307% at Amazon compared to the same period of fiscal 2022. GLUCODOWN® Cherry experienced a 146% YTD sales growth increase at Amazon to the end of Q2 2023 compared to the same period of fiscal 2022.

Glucose Health, Inc. (OTC PINK:GLUC) reported strong fiscal 2022 results, achieving over $1 million in annual revenue for the first time, totaling $1,072,655, a 12% increase from $953,681 in 2021. The company also saw gross profits rise 11% to $456,715. With zero debt and minimal liabilities, GLUC continues as an emerging growth company. The successful launch of GLUCODOWN® flavors, available on Amazon and CVS, supports this growth. In 2023, Glucose Health plans to expand its distribution and launch new brands like FIBER UP® and be rite®. The company maintains a strong online and in-store presence with positive customer feedback.

Glucose Health, Inc. (OTC: GLUC) announced key corporate updates on November 3, 2022. Three candidates accepted nominations as independent directors, and committees for Audit, Compensation, and Corporate Governance have been established. A PCAOB firm has been appointed as auditor, completing audits for fiscal years 2020 and 2021, alongside interim reviews for 2022. A new Chief Accounting Officer has been appointed to oversee accounting matters. The company specializes in beverages tailored for diabetics and plans to launch a fiber-infused drink targeting the fiber-deficient population in the U.S.

Glucose Health, Inc. (OTC: GLUC) reported significant financial growth for Q3 2022, with revenues of $340,681, a 45% increase from Q3 2021. Gross profit soared to $153,789, marking a 148% rise year-over-year. The company achieved a net income of $8,091, a notable turnaround from a net loss of $133,160 in Q3 2021. Additionally, Glucose Health is preparing for a planned up-listing to the NASDAQ Capital Market, with an update expected by the week of October 31, 2022.

Glucose Health, Inc. (OTC Pink: GLUC) announced significant changes to its Board of Directors amid concerns regarding potential violations of securities laws connected to Celsius Holdings. The company's CEO and a board member from Celsius resigned following the revelation of an SEC investigation into Celsius. Consequently, 1.8 million shares underlying the resigned directors' warrants were canceled, reducing GLUC's fully diluted share count from 22.1 million to 20.3 million. This restructuring positions Glucose Health to refocus on its unique market of functional, diabetic-friendly beverages.